2-Methyltetrahydrothiophen-3-one
Common Name: |
2-Methyltetrahydrothiophen-3-one |
IUPAC Name: |
2-methylthiolan-3-one |
Molecular Formula: |
C5H8OS |
SMILES: |
CC1C(=O)CCS1 |
Inchi: |
1S/C5H8OS/c1-4-5(6)2-3-7-4/h4H,2-3H2,1H3 |
Inchi Key: |
YMZZPMVKABUEBL-UHFFFAOYSA-N |
Cas No: |
13679-85-1 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
3 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
116.18 |
Mass (g/mol) |
116.03 |
Molar Refractivity |
31.83 |
Net Charge |
|
HBD |
|
HBA |
1 |
Rt Bonds |
0 |
Rings |
1 |
TPSA |
42.37 |
Hetero Atoms |
2 |
Heavy Atoms |
7 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
82.00 @ 28.00 mm Hg |
Vapor Pressure (mmHg@25.00 °C) |
0.917 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.80 |
LogP |
1.081 |
iLOGP |
1.49 |
XLOGP3 |
0.83 |
WLOGP |
1.08 |
MLOGP |
0.62 |
ESOL Log S |
-1.08 |
ESOL Solubility (mg/ml) |
9.59 |
ESOL Solubility (mol/l) |
0.083 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-1.30 |
Ali Solubility (mg/ml) |
5.79 |
Ali Solubility (mol/l) |
0.05 |
Ali Class |
Very soluble |
Silicos-IT LogSw |
-1.09 |
Silicos-IT Solubility (mg/ml) |
9.42 |
Silicos-IT Solubility (mol/l) |
0.08 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-6.42 |
Bioavailability Score |
0.55 |
Caco2 |
0 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.495 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.403 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |